Journal article
Oxidative activation of the Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis
Vascular pharmacology, Vol.60(2), pp.75-83
02/2014
DOI: 10.1016/j.vph.2014.01.001
PMCID: PMC3955051
PMID: 24418021
Abstract
Activation of the Ca2+/calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activation site of CaMKII alters vascular smooth muscle cell (VCMC) proliferation, migration and apoptosis in vitro and neointimal formation in vivo. VSMC isolated from a knock-in mouse with oxidation-resistant CaMKIIδ (CaMKII M2V) displayed similar proliferation but decreased migration and apoptosis. Surprisingly, ROS production and expression of the NADPH oxidase subunits p47 and p22 were decreased in M2V VSMC, whereas superoxide dismutase 2 protein expression was upregulated. In vivo, after carotid artery ligation, no differences in neointimal size or remodeling were observed. In contrast to VSMC, CaMKII expression and autonomous activity were significantly higher in M2V compared to WT carotid arteries, suggesting that an autoregulatory mechanism determines CaMKII activity in vivo. Our findings demonstrate that preventing oxidative activation of CaMKII decreases migration and apoptosis in vitro and suggest that CaMKII regulates ROS production. Our study presents novel evidence that CaMKII expression in vivo is regulated by a negative feedback loop following oxidative activation.
[Display omitted]
Details
- Title: Subtitle
- Oxidative activation of the Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis
- Creators
- Linda J Zhu - Department of Medicine, Iowa City, IA, United StatesPaula J Klutho - Department of Medicine, Iowa City, IA, United StatesJason A Scott - Department of Medicine, Iowa City, IA, United StatesLitao Xie - Department of Medicine, Iowa City, IA, United StatesElizabeth D Luczak - Department of Medicine, Iowa City, IA, United StatesMegan E Dibbern - Department of Medicine, Iowa City, IA, United StatesAnand M Prasad - Department of Medicine, Iowa City, IA, United StatesOmar A Jaffer - Department of Medicine, Iowa City, IA, United StatesAshlee N Venema - Department of Medicine, Iowa City, IA, United StatesEmily K Nguyen - Department of Medicine, Iowa City, IA, United StatesXiaoqun Guan - Department of Medicine, Iowa City, IA, United StatesMark E Anderson - Department of Medicine, Iowa City, IA, United StatesIsabella M Grumbach - Department of Medicine, Iowa City, IA, United States
- Resource Type
- Journal article
- Publication Details
- Vascular pharmacology, Vol.60(2), pp.75-83
- DOI
- 10.1016/j.vph.2014.01.001
- PMID
- 24418021
- PMCID
- PMC3955051
- NLM abbreviation
- Vascul Pharmacol
- ISSN
- 1537-1891
- eISSN
- 1879-3649
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 02/2014
- Academic Unit
- Cardiovascular Medicine; Radiation Oncology; Internal Medicine
- Record Identifier
- 9984094396202771
Metrics
19 Record Views